CellXplore Overview
- Founded
-
2007
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
CellXplore General Information
Description
Operator of a technology platform intended to facilitate the discovery of biomarkers. The company's technology platform is into identifying biomarkers for non-invasive diagnosis of breast cancer using biochemical analysis of blood samples, enabling clients to classify disease-specific biomarkers and target for drug discovery in human diseases and also apply it in the field of animal science.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 120 Albany Street, Tower II
- Suite 850
- New Brunswick, NJ 08901
- United States
+1 (732) 000-0000
CellXplore Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Sep-2018 | 00000 | Completed | Out of Business | ||
| 1. Early Stage VC | 01-Oct-2007 | 00000 | 00000 | Completed | Startup |